Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers
ABSTRACT Despite the widespread use of currently available serum phosphate management options, elevated serum phosphate is common in patients with end‐stage kidney disease on dialysis. Characteristics of currently available phosphate binders that lead to poor patient experiences such as large drug v...
Saved in:
Main Authors: | Pablo E. Pergola, Melanie S. Joy, Armando Garsd, Steve J. Hasal, Atul Khare, Guru Reddy, Pramod Gupta, William F. Finn |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Science |
Subjects: | |
Online Access: | https://doi.org/10.1111/cts.70116 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden
by: Brunelle Bruna Scavello Coelho Ferezin, et al.
Published: (2025-01-01) -
New insights into the mechanism of triphenyl phosphate and its metabolite diphenyl phosphate in diabetic kidney disease
by: Ting Fang, et al.
Published: (2025-02-01) -
A network meta-analysis of therapies for hyperphosphatemia in CKD based on randomized trials
by: Congyang Zheng, et al.
Published: (2025-01-01) -
Hepatocyte Nuclear Factor 1 Beta Mutation-associated Newborn Onset of Glomerulocystic Kidney Disease: A Case Presentation
by: Nilüfer Göknar, et al.
Published: (2021-12-01) -
Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Yu-Ling Lin, et al.
Published: (2025-01-01)